comparemela.com

Latest Breaking News On - படியெடுத்தல் - Page 4 : comparemela.com

Welcome To IANS Live - SCIENCE - Record group meet transcriptions with new Microsoft app

A product of Microsoft s experimental division Garage, Group Transcribe uses a multi-device approach to provide real-time, high quality transcription and translation, so users can be more present and productive during in-person meetings and conversations.

CRISPR screen identifies clinically approved immunosuppressants that could treat coronavirus infections

CRISPR screen identifies clinically approved immunosuppressants that could treat coronavirus infections Researchers in Switzerland and Germany have identified host cell factors required for coronavirus replication that could serve as targets for treatment with clinically-approved drugs. The team found that several autophagy-related genes were common host defense factors required for the replication of both endemic and emerging coronaviruses. These coronaviruses include the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic. Autophagy – cellular response to stressors such as hypoxia or infection – involves the recycling of proteins and organelles to maintain homeostasis. Various trafficking pathways enable the transportation of cytoplasmic material to the lysosome, where it is destroyed.

High-throughput genetic analysis can help dissect the mechanism of disease inheritance

High-throughput genetic analysis can help dissect the mechanism of disease inheritance Many genetic variants have been found to have a linkage with genetic diseases, but the understanding of their functional roles in causing diseases are still limited. An international research team, including a biomedical scientist from City University of Hong Kong (CityU), has developed a high-throughput biological assay technique which enabled them to conduct a systematic analysis on the impact of nearly 100,000 genetic variants on the binding of transcription factors to DNA. Their findings provided valuable data for finding key biomarkers of type 2 diabetes for diagnostics and treatments. And they believe that the new technique can be applied to studies of variants associated with other genetic diseases.

Kronos Bio Announces First Patient Dosed in Phase 1/2 Clinical Trial of KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers

Kronos Bio Announces First Patient Dosed in Phase 1/2 Clinical Trial of KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.